The Interrelationship Between Sexual Networks and Impact on STI Transmission: Evidence from Mathematical Modelling
Christian Althaus
University of Bern, Bern, Switzerland

Global Public Health Approaches to Gonorrhea Prevention and the Threat of Antibiotic Resistance: Perspectives from Brazil and Latin America
Adele Schwartz Benzaken
Tropical Medicine Foundation, Manaus, Amazonas, Brazil

Theoretical Overview on Methods Including RCTs and Other Potential Methodologies- Advantages and Disadvantages
Isolde Birdthistle
The London School of Hygiene & Tropical Medicine, London, UK

Resistance-Guided Therapy for M.genitalium: Impact of Diagnostic Resistance Assays on Practice and Policy
Catriona Bradshaw
Central Clinical School, Monash University, Australia

Resurgent STIs in LMIC in Reproductive Age
Connie Celum
University of Washington, Seattle, USA

The Role of Oral-Anal Transmission in Persistence of Chlamydial Infection
Henry de Vries
University of Amsterdam, Amsterdam, Netherlands

Point of Care and Home Testing Opportunities: Implications for Quality Public Health Practice
Patricia Dittus
Centers for Disease Control and Prevention, USA

The Role of Sexual Networks in the Global Spread of Antimicrobial-Resistance Enteric Infections
Nigel Field
University College London, London, UK

Use of Whole Genome Sequencing to Explore Transmission Between Sexual Networks in an STI Outbreak
Helen Fifer
Public Health England,  London, UK

HPV Self-Collection in Peru
Application of a Cascade Approach for Guiding Prevention of Congenital Syphilis
Patricia Garcia
Universidad Peruana Cayetano Heredia, Lima, Peru

HPV Based Cervical Screening: New Evidence and Current State of the Art
Suzanne Garland
The Royal Women’s Hospital, Parkville, Australia

New Approaches for STI Vaccines: Syphilis
Lorenzo Giacani
University of Washington, Seattle, USA

CRISPR Diagnostics: Expanding the Nucleic Acid Detection Toolbox by Harnessing Microbial Diversity Diagnosis
Jonathan Gootenberg
Massachusetts Institute of Technology, Cambridge, USA

Pop ART – Applying RCTs to the Real World – Opportunities and Challenges Faced in Implementing and Evaluating Large Scale RCTs
Richard Hayes
The London School of Hygiene & Tropical Medicine, London, UK

Chemsex and New STI/HIV Diagnoses Among Gay, Bisexual and Other Men Who Have Sex with Men Attending Sexual Health Clinics
Aseel Hegazi
St George’s University Hospital Foundation Trust, London, UK

Evaluating Complex Public Health Issue Violence- Understanding and Measuring Violence and Evaluating Violence Interventions- Lessons from STRIVE
Lori Heise
Johns Hopkins University, Baltimore, USA

Does Azithromycin Have a Future in the Treatment of Gonorrhoea and Chlamydial Infection?
Anatomical Sites of Infection: Biomedical, Modeling, Behavioral, and Programmatic Considerations for STI Prevention: Biomedical Considerations
Jane Hocking
University of Melbourne, Melbourne, Australia

Cervical Cancer Prevention in LMIC: Are We on the Path to Elimination?
Megan Huchko
Duke University, Durham, USA

Mobilising for Health and Rights: A History of Sex Worker Activism in India
Smarajit Jana
Sonagachi Research and Training Institute, Kolkata, India

New Approaches to STI Diagnosis and Prevention: Proteomics for T. pallidum
Chris Kenyon
Institute of Tropical Medicine, Antwerp, Belgium

Do Rectal Bacterial STIs in Women Matter? Who Should We Test and When?
Christine Khosropour
University of Washington, Seattle, USA

Implementing Molecular Testing to Predict Neisseria gonorrhoeae Susceptibility in Clinical Practice
Jeffrey D. Klausner
Fielding School of Public Health, USA

Reducing the global burden of infectious diseases through precision infection management (PIM)
Ian Lewis
University of Calgary, Calgary, Canada

Intersectionality, Criminalisation and Sexual Health
Carmen Logie
University of Toronto, Toronto, Canada

Global Public Health Approaches to Gonorrhea Prevention and the Threat of Antibiotic Resistance: Perspectives from Europe
Otilia Mårdh
European Centre for Disease Prevention and Control (ECDC), Solna, Sweden

Anatomical Sites of Infection: Biomedical, Modeling, Behavioral, and Programmatic Considerations for STI Prevention
Programmatic Considerations
Jeanne Marrazzo
University of Alabama, Birmingham, USA

Anatomical Sites of Infection: Biomedical, Modeling, Behavioral, and Programmatic Considerations for STI Prevention
Behavioral Considerations
Catherine Mercer
University College London, London, UK

Treatment of Bacterial Vaginosis
Caroline Mitchell
Harvard University, Cambridge, USA

Prematurity and STI – Value of Screening and Treatment
Deborah Money
University of British Columbia, Vancouver, Canada

Cascades and Other Approaches to Guide PrEP Programming
Sinead Delany Moretlwe
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa

The Importance of Self-Care Interventions to Reduce STIs
Manjulaa Narasimhan
World Health Organization, Geneva, Switzerland

T. pallidum in vitro Growth
Steven Norris
University of Texas, Houston, USA

Maximizing the Acceptability, Feasibility and Validity of Sexual Network Studies: Lessons from the Field 
Abigail Norris Turner
Ohio State University, Ohio, USA

Empowerment and Harm Reduction – Self-Testing Among Female Sex Workers
Catherine Oldenburg
University of California, San Francisco, USA

Should Enteric Infections in MSM Always be Treated?
Mark Pakianathan
St George’s University Hospital Foundation Trust, London, UK

Pigtailed Macaque Model of STIs
Dorothy Patton
University of Washington, Seattle, USA

Using Multiple Data Sources for Programme Evaluation: Integration of Program Monitoring Data with Other Research Studies
BM Ramesh
University of Manitoba, Winnipeg, Canada

Authentic and successful community engagement for STI/HIV prevention, screening, and treatment in rural and urban setting
Scott Rhodes
University of North Carolina, USA

Screening Women for Bacterial STIs: Should We Scale-Back?
Jonathan Ross
University of Birmingham, Birmingham, UK

Global Public Health Approaches to Gonorrhea Prevention and the Threat of Antibiotic Resistance: Perspectives from North America
Karen Schlanger
Center for Disease Control and Prevention, Atlanta, USA

Hepatitis C in HIV-Negative MSM – A Growing Concern?
Axel J. Schmidt
London School of Hygiene and Tropical Medicine, London, UK

New Approaches for STI Vaccines: Gonorrhea
Kate Seib
Griffith University, Brisbane, Australia

Applications of the HIV Prevention Cascade Framework in Work Evaluating the DREAMS Programme
HIV Self-Testing at the STAR Project
Maryam Shahmanesh
London’s Global University, London, UK

Global Public Health Approaches to Gonorrhea Prevention and the Threat of Antibiotic Resistance: Perspectives from Thailand and Asia
Pachara Sirivongrangson
Department of Disease Control, Thailand Ministry of Public Health, Nonthaburi, Thailand

Anatomical Sites of Infection: Biomedical, Modeling, Behavioral, and Programmatic Considerations for STI Prevention
Modeling Considerations
Ian Spicknall
Centers for Disease Control and Prevention, Atlanta, USA

New Approaches for STI Vaccines: Chlamydial Nanoparticle Vaccine
Michael Starnbach
Harvard Medical School, Cambridge, USA

N. gonorrhoeae  in Cervical Explants
Daniel Stein
University of Maryland, College Park, USA

The Use of Existing Data to Plan HIV Prevention Activities in Zimbabwe
Isaac Taramusi
National AIDS Council, Harare, Zimbabwe

New Approaches for STI Vaccines: HPV Therapeutic Vaccine
Connie Thimble
Johns Hopkins University, Baltimore, USA

The North American Overdose Crisis: How Structural Violence, Prohibition and Stigma Have Paralyzed Our Response
Mark Tyndall
BC Centre for Disease Control, Vancouver, Canada

Chlamydia trachomatis, Trichomonas vaginalis and Treponema pallidum Infections in Macaques: Effects on Simian HIV AcquisitionSundaram Ajay Vishwanathan
Center for Disease Control and Prevention, Atlanta, USA

Syphilis Self-Testing Among Gay Men in China
Cheng Wang
Southern Medical University, Guangzhou, China

Impact of HIV PrEP on Risk Compensation and STI Epidemiology – What Does the Evidence Show?
Helen Ward
Imperial College London, London, UK

New Approaches to STI Diagnosis and Prevention: Nanoparticle Delivery of Drugs to Mucosal Surfaces
Kim Woodrow
University of Washington, Seattle, USA

Building STD Clinical Infrastructure in LMIC – Role of General vs. Specialized Infrastructure
Ligang Yang
Southern Medical University, Guangzhou, China